Daily programme - 08 June 2026

Monday 08 June 2026

Time Session
08:30
10:00
(pre-selected participants only; UPDATE: this session is fully booked)
MircoJ.Friedrich Chair German Cancer Research Center and HI-STEM GmbHGermany
Room F1+2+3
09:00
14:00
Women in Leadership
(Separate pre-registration required)
Off-site Venue
10:00
12:00
AttilaPatócs Chair National Institute of OncologyHungary
JózsefTóvári Chair National Institute of Oncology BudapestHungary
  • 10:00
    Introduction
    AttilaPatócs Chair National Institute of OncologyHungary
  • 10:05
    Important roles of selenoproteins and redox biology in cancer
    BeataBiri-Kovacs Speaker National Institute of OncologyHungary
  • 10:25
    Roles of transsulfuration pathway in pancreatic ductal adenocarcinoma
    ÁgnesCzikora Speaker National Institute of OncologyHungary
  • 10:45
    Glucocorticoid receptor signaling in breast cancer progression
    HenriettButz Speaker National Institute of OncologyHungary
  • 11:05
    Epigenetic Mechanisms Driving Therapy Resistance in Cancer
    Sándor Spisák Speaker HUN-REN, Institute of Molecular Life SciencesHungary
  • 11:25
    Expanding CAR T cell therapy to solid tumors
    ÁrpádSzöőr Speaker University of Debrecen, Faculty of MedicineHungary
  • 11:45
    Conclusions
    JózsefTóvári Chair National Institute of Oncology BudapestHungary
Room F6+7+8
10:30
12:00
This session focuses on career progression, offering participants the opportunity to engage directly with the four Award Winners in an informal, highly interactive format. Each expert will begin with a 7 minute personal introduction, sharing their career path, key decisions, and lessons learned. A moderator may pose follow-up questions to deepen the discussion and draw out practical insights. The floor is then opened to the audience for an open Q&A, encouraging participants to ask questions in an “Ask Me Anything”–style exchange. Designed as a fully interactive session, this format features no slides and no screen, prioritizing conversation, accessibility, and direct engagement between Award Winners and participants.
MartaKovatcheva Moderator IFOMItaly
  • 10:40
    Introduction
    AyeletErez Expert The Weizmann Institute of ScienceIsrael
  • 10:50
    Introduction
    DanielKirschenbaum Expert Deutsches Krebsforschungszentrum (DKFZ)Germany
  • 11:00
    Ask Me Anything - Audience Q&A
Career Development Area
(pre-selected participants only; UPDATE: this session is fully booked)
MatheusHenriqueDias Chair Princess Máxima CenterNetherlands
Room F1+2+3
12:00
14:00
Lunch Break / Exhibition (Poster and Exhibition Hall)
Poster and Exhibition Hall
Room P1+2+3
12:00
20:00
Exhibition
Poster and Exhibition Hall
12:15
13:00
This symposium addresses the critical shift toward multi-resolution, multi-modal approaches that enable the precise deconstruction of the tumor ecosystem to achieve a system-level understanding of cancer progression. The session will begin with an overview of emerging innovations expanding the resolution and scope of cancer research, followed by expert‑led research demonstrating the utility of spatial transcriptomics for tumor microenvironment analysis and high‑plex functional proteomics for uncovering protein‑level drivers of cancer biology. Building on these applications and using Illumina Connected Multiomics (ICM) as a framework, an R&D‑led technical deep dive will examine analytical considerations for single‑omic and integrated multiomic analysis across single‑cell, spatial, transcriptomic, proteomic, genomic, and epigenomic data. Through practical examples, this session will demonstrate how AI guided workflows, structured data exploration, and intuitive visualisation make advanced multiomic analysis accessible, enabling researchers to confidently apply multiomic approaches in their own studies. Join us to explore how these multidimensional results, powered by high‑fidelity sequencing and accessible data analytics are providing the clarity needed to decipher the functional drivers of cancer and advance the next wave of precision oncology.
  • 12:15
    Expanding the Resolution and Scope of Multi‑modal Cancer Research with Innovative Solutions
    SedlyarovaNadia Industry Speaker IlluminaUnited States
  • 12:30
    The power of OvaPrint and novel multi-modal methods for the detection of ovarian cancer
    BodourSalhia Industry Speaker Inaugural (Interim) Chair & Associate Professor, Dept of Cancer Biology Keck School of Medicine of USCUnited States
Room F1+2+3
Biology is complex, and the mechanisms that drive biological systems are challenging to decipher. Examining any single layer of biology can provide a valuable perspective, but it reveals only part of the picture. Bruker Spatial Biology delivers best-in-class solutions designed to work together as a cohesive ecosystem. By providing high fidelity resolution and information depth across layers of biological complexity, Bruker Spatial Biology enables insights that cannot be achieved by single layer approaches, accelerating discovery through translational cancer research. Prof. Pagani will exemplify how his laboratory is using CosMx Same-Cell Multiomics to determine metastatic cell states in colorectal cancer.
  • 12:15
    Introductory words and workshop overview by Gareth Jones
    JonesGareth Industry Moderator/ Chair Bruker Cellular Analysis/ Bruker Spatial Biology
  • 12:20
    Resolving Cancer Across Its Biological Layers with Single-Cell and Spatial Biology
    JosephBeechem Industry Speaker Bruker Spatial BiologyUnited States
    ThomasCampbell Industry Speaker BrukerUnited States
  • 12:45
    Molecular and Spatial Determinants of Metastatic Cell State Acquisition in Colorectal Cancer
    MassimilianoPagani Industry Speaker IFOM/University of MilanItaly
Room F9+10
12:30
13:45
(open to EACR Early Career & Student Members, pre-registration required)
Career Development Area
13:15
14:00
This symposium addresses the critical shift toward multi-resolution, multi-modal approaches that enable the precise deconstruction of the tumor ecosystem to achieve a system-level understanding of cancer progression. The session will begin with an overview of emerging innovations expanding the resolution and scope of cancer research, followed by expert‑led research demonstrating the utility of spatial transcriptomics for tumor microenvironment analysis and high‑plex functional proteomics for uncovering protein‑level drivers of cancer biology. Building on these applications and using Illumina Connected Multiomics (ICM) as a framework, an R&D‑led technical deep dive will examine analytical considerations for single‑omic and integrated multiomic analysis across single‑cell, spatial, transcriptomic, proteomic, genomic, and epigenomic data. Through practical examples, this session will demonstrate how AI guided workflows, structured data exploration, and intuitive visualisation make advanced multiomic analysis accessible, enabling researchers to confidently apply multiomic approaches in their own studies. Join us to explore how these multidimensional results, powered by high‑fidelity sequencing and accessible data analytics are providing the clarity needed to decipher the functional drivers of cancer and advance the next wave of precision oncology.
  • 13:15
    Introduction
    TalaKhosroheidari Industry Speaker SomaLogic/IlluminaUnited States
  • 13:20
    Plasma Proteomics and AI: Redefining Precision Oncology
    YehonatanElon Industry Speaker OncoHostIsrael
  • 13:40
    Making Sense of Multiomics Data: Technical Considerations for Integrated Analysis and Visualisation
    JoachimScmid Industry Speaker IlluminaUnited States
Room F1+2+3
γδ T cells are increasingly recognized for their role in anti-tumor immunity and Vδ1 T cells have been reported as the predominant γδ subset infiltrating the microenvironment of several cancers. However, their contribution in this setting remains unclear and flow cytometry alone has provided limited insights into their functionality. In this symposium, Prof. Domenico Mavilio (IRCCS Humanitas Research Hospital, Milan, Italy) will present how transcriptome and repertoire profiling at bulk and single cell resolution can clarify γδ T-cell states and provide clues on tumor escape mechanisms. By linking transcriptional state, repertoire, and therapeutic response, this work underscores the potent antitumor role of Vδ1 T cells in endometrial cancer and highlights their potential as therapeutic targets to enhance anti–PD-1 checkpoint inhibitor strategies in the future.
  • 13:15
    Introduction by Moderator
    EhranNas Industry Moderator/ Chair QIAGENNetherlands
  • 13:20
    Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution
    DomenicoMavilio Industry Speaker IRCCS Humanitas Research HospitalItaly
  • 13:50
    Q&A with Prof. Mavilio
    DomenicoMavilio Industry Speaker IRCCS Humanitas Research HospitalItaly
Room F9+10
14:00
15:15
Siddhi Maniyar Co-Chair FEBS PressUnited Kingdom
YardenaSamuels Co-Chair Weizmann Institute of ScienceIsrael
  • 14:00
    Decoding the Dark Immunopeptidome: The Role of Translational Aberrations in Immune Surveillance
    YardenaSamuels Speaker Weizmann Institute of ScienceIsrael
  • 14:25
    From Dark to Detectable -The Cancer Proteogenomics
    JanneJanne Lehtiö Speaker Karolinska Institutet and SciLifeLabSweden
  • 14:50
    A functional map of the cancer dark proteome
    John R.Prensner Speaker University of Michigan Medical SchoolUnited States
Room F1+2+3
ReneBernards Chair Netherlands Cancer Institute (NKI)Netherlands
  • 14:00
    Introduction of the Mark Foundation for Cancer Research
    BeckyBish Presenter The Mark Foundation for Cancer ResearchUnited States
  • 14:05
    2026 EACR - Mark Foundation - Pezcoller Foundation Rising Star Award Lecture: The Story Behind a Picture: From Snapshots to Biological Narratives
    DanielKirschenbaum Award Lecture Deutsches Krebsforschungszentrum (DKFZ)Germany
  • 14:25
    EACR - Mark Foundation Postdoctoral Fellowship Award Lecture: A role for mitochondrial one carbon metabolism in early pancreatic cancer development
    MarthaZarou Award Lecture The Francis Crick InstituteUnited Kingdom
  • 14:40
    EACR - Mark Foundation Postdoctoral Fellowship Award Lecture: Dissecting tissue-resident and circulating trajectories to CD8 T cell dysfunction in the tumor microenvironment
    ChristinaMetoikidou Award Lecture Netherlands Cancer InstituteNetherlands
  • 14:55
    EACR - Mark Foundation Postdoctoral Fellowship Award Lecture: Unlocking CD8+ T cell anti-tumor activity in brain metastasis
    JulieMarie Mazet Award Lecture Ludwig Cancer Research - Lausanne Branch - University of Lausanne Switzerland
Room F6+7+8
15:15
15:45
Meet and Greet EACR Ambassador and Solo Travellers (at the Networking Lounge)
Networking Lounge
Coffee Break / Exhibition (Poster and Exhibition Hall)
Poster and Exhibition Hall
Room P1+2+3
15:45
18:20
YardenaSamuels Chair Weizmann Institute of ScienceIsrael
  • 15:45
    Opening Address
    YardenaSamuels Chair Weizmann Institute of ScienceIsrael
  • 15:50
    Patient involvement in cancer research
    Marisol S.Soengas Speaker Spanish National Cancer Research Center (CNIO)Spain
  • 15:55
    Opening Keynote Lecture: A Tale of 3 Biomarkers - diagnosis, prognosis and therapy scheduling
    CarolineDive Keynote Speaker CRUK Cancer Biomarker CentreUnited Kingdom
  • 16:40
    Pezcoller Award Presentation and Introduction of the Award Recipients
    EnzoGalligioni Presenter The Pezcoller FoundationItaly
  • 16:50
    The Pezcoller Foundation-EACR Translational Cancer Researcher Award 2026 - Unravelling the Mysteries of Kidney Cancer – A Journey from Genetics to Immunology
    SamraTurajlic Award Lecture Cancer Research UK, The Manchester InstituteUnited Kingdom
  • 17:35
    The Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award 2026 - Reactivation of a Fetal Liver Metabolic Program Promotes Extrahepatic Tumorigenesis
    AyeletErez Award Lecture The Weizmann Institute of ScienceIsrael
Room P1+2+3
18:20
18:35
EACR General Assembly and Awards Ceremony (EACR Members only)
P1+2+3
Room P1+2+3
Welcome Reception (Exhibition Area)
Poster and Exhibition Hall
Room P1+2+3
18:45
19:00
CancerTools.org Industry Spotlight Session: Accelerating cancer research with CancerTools: Unlocking discovery with advanced models
Malathi Raman Srivastava is a Senior Product Marketing Manager at CancerTools managing the breast, lung and skin cancer product portfolios including patient-derived xenograft (PDX) models. She previously worked at Bit Bio Ltd as a Product Development Manager and at Takara Bio Europe as a Senior Product Manager. She holds a PhD from Imperial College London and has done post-doctoral research at the Leeds Institute of Molecular Medicine in Leeds, U.K.
MalathiRaman Srivastava Industry Speaker CancerTools
Spotlight Theatre
19:15
19:30
Element Biosciences Industry Spotlight Session: Revealing a Deeper View of Cancer with 5D Biology
AgnieszkaCiesielska Industry Speaker Element BiosciencesPoland
Spotlight Theatre